Your browser doesn't support javascript.
Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study.
Pan, Lei; Wang, Runsheng; Yu, Na; Hu, Chao; Yan, Junhong; Zhang, Xiaomin; Wang, Tao; Hao, Jungui; Gao, Fuquan; Liu, Tonggang; Wang, Jing; Liu, Xiaojing; Mu, Mi; Huang, Wei; Guo, Yongzhong; Lv, Changjun; Wang, Xiaozhi; Tu, Lei; Wan, Kun; Xu, Guogang.
  • Pan L; Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
  • Wang R; Department of Respiratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Medical College of PLA, Chinese PLA General Hospital, Beijing, China.
  • Yu N; Department of Gynecology, Shandong Provincial Third Hospital, Jinan, China.
  • Hu C; Department of Respiratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Medical College of PLA, Chinese PLA General Hospital, Beijing, China.
  • Yan J; Department of Ultrasound, Binzhou Medical University Hospital, Binzhou, China.
  • Zhang X; Department of Nephrology, Binzhou Medical University Hospital, Binzhou, China.
  • Wang T; Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
  • Hao J; Department of Infection Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Gao F; Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
  • Liu T; Department of Infectious Diseases, Binzhou Medical University Hospital, Binzhou, China.
  • Wang J; Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
  • Liu X; Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
  • Mu M; Department of Disease Prevention and Control, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
  • Huang W; Department of Infection Diseases, Huanggang Central Hospital, Huanggang, China.
  • Guo Y; Department of Respiratory Medicine, Xuzhou Central Hospital, The Xuzhou School of Clinical Medicine of Nanjing Medical University, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, China.
  • Lv C; Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
  • Wang X; Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China. bzyxy3013@163.com.
  • Tu L; Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. tulei_1985@126.com.
  • Wan K; Medical Supplies Center, Chinese PLA General Hospital, Beijing, China. 301wk@sina.com.
  • Xu G; The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China. guogang_xu@163.com.
Eur J Clin Microbiol Infect Dis ; 40(6): 1245-1252, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1030727
ABSTRACT
At present, it has been noticed that some patients recovered from COVID-19 present a recurrent positive RNA test of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) after being discharged from hospitals. The purpose of the current study was to characterize the clinical features of re-hospitalized patients with recurrent SARS-CoV-2 positive results. From January 12 to April 1 of 2020, our retrospective study was conducted in China. The exposure history, baseline data, laboratory findings, therapeutic schedule, and clinical endpoints of the patients were collected. All the patients were followed until April 10, 2020. Among all COVID-19 patients included in the current study, there were 14 re-hospitalized patients due to recurrent positive tests of SARS-CoV-2 RNA. Fever (11 [78.6%]), cough (10 [71.4%]), and fatigue (7 [50.0%]) were the most common symptoms on the patient's first admission, and less symptoms were found on their second admission. The average duration from the onset of symptoms to admission to hospital was found to be 8.4 days for the first admission and 2.6 days for the second admission (P = 0.002). The average time from the detection of RNA (+) to hospitalization was 1.9 days for the first admission and 2.6 days for the second admission (P = 0.479), and the average time from RNA (+) to RNA (-) was 11.1 days for the first admission and 6.3 days for the second admission (P = 0.030). Moreover, the total time in hospital was 18.6 days for the first admission and 8.0 days for the second admission (P = 0.000). It may be necessary to increase the isolation observation time and RT-PCR tests should be timely performed on multiple samples as soon as possible.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Readmission / RNA, Viral / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Eur J Clin Microbiol Infect Dis Journal subject: Communicable Diseases / Microbiology Year: 2021 Document Type: Article Affiliation country: S10096-020-04151-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Readmission / RNA, Viral / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Eur J Clin Microbiol Infect Dis Journal subject: Communicable Diseases / Microbiology Year: 2021 Document Type: Article Affiliation country: S10096-020-04151-9